NCT03867994View on ClinicalTrials.gov

Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy.

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

May 15, 2017

Study Completion Date

May 15, 2017

Conditions
Contrast-induced Nephropathy
Interventions
DRUG

Atorvastatin

DRUG

Carvedilol

DRUG

saline

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

rabab ahmed mohamed

OTHER

NCT03867994 - Comparison of Carvedilol and Atorvastatin for Preventing of Contrast-Induced Nephropathy. | Biotech Hunter | Biotech Hunter